Approval · Notice of Compliance 17208 · 2015
ADVANTAGE MULTI 18: Notice of Compliance 17208
Issued August 19, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17208
- Date
- August 19, 2015
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling update
- Therapeutic class
- Antiparasitic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADVANTAGE MULTI 18 | 02263513 | Marketed |
Medicinal ingredients
- MOXIDECTIN 8 MG per 0.8ML
- IMIDACLOPRID 80 MG per 0.8ML